REGISTERED NUMBER: 09487658 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

PBJ Medical Ltd

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

4

DIRECTORS:

Dr P R A Johnson

Dr B A Xavier

REGISTERED OFFICE:

Spectrum House

2B Suttons Lane

Hornchurch

Essex

RM12 6RJ

REGISTERED NUMBER:

09487658 (England and Wales)

ACCOUNTANTS:

Johal & Company

Chartered Certified Accountants

& Registered Auditors

Spectrum House

2B Suttons Lane

Hornchurch

Essex

RM12 6RJ

FIXED ASSETS

Tangible assets

4

28,296

37,728

Investments

5

549,589

363,348

577,885

401,076

CURRENT ASSETS

Cash at bank

23,563

17,121

CREDITORS

Amounts falling due within one year

6

55,593

11,523

NET CURRENT (LIABILITIES)/ASSETS

(32,030

)

5,598

TOTAL ASSETS LESS CURRENT LIABILITIES

545,855

406,674

CREDITORS

Amounts falling due after more than one year

7

49,194

55,053

NET ASSETS

496,661

351,621

CAPITAL AND RESERVES

Called up share capital

101

101

Revaluation reserve

8

54,772

127,225

Retained earnings

441,788

224,295

SHAREHOLDERS' FUNDS

496,661

351,621

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 December 2025 and were signed on its behalf by:

Dr B A Xavier - Director

Dr P R A Johnson - Director

1.	STATUTORY INFORMATION

PBJ Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

25% on reducing balance

Motor vehicles

-

25% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Investments

Investments comprise of investments in unquoted equity instruments which are measured

at fair value. Fair value is estimated by using market value.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Motor

fittings

vehicles

Totals

£

£

£

COST

At 1 April 2024

and 31 March 2025

738

49,770

50,508

DEPRECIATION

At 1 April 2024

654

12,126

12,780

Charge for year

21

9,411

9,432

At 31 March 2025

675

21,537

22,212

NET BOOK VALUE

At 31 March 2025

63

28,233

28,296

At 31 March 2024

84

37,644

37,728

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST OR VALUATION

At 1 April 2024

363,348

Additions

255,325

Disposals

(121,570

)

Revaluations

44,313

Dividends received

8,173

At 31 March 2025

549,589

NET BOOK VALUE

At 31 March 2025

549,589

At 31 March 2024

363,348

Cost or valuation at 31 March 2025 is represented by:

Other

investments

£

Valuation in 2024

549,589

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Hire purchase contracts

4,795

4,795

Taxation and social security

35,994

42

Other creditors

14,804

6,686

55,593

11,523

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.3.25

31.3.24

£

£

Bank loans

4,041

6,514

Hire purchase contracts

22,353

25,739

Other creditors

22,800

22,800

49,194

55,053

8.

RESERVES

Revaluation

reserve

£

At 1 April 2024

127,225

Revaluation reserve

(72,453

)

At 31 March 2025

54,772